• Dilatation of thoracic aorta 1.5x

Incidence

  • M > F
  • ≈ 3% of pts > 65yo

Classification

  • Ascending aortic aneurysms
    • Arise anywhere from the aortic valve to the brachiocephalic trunk (ie, innominate artery; 60 percent)
  • Aortic arch aneurysms
    • Include any thoracic аոeuryѕm that involves the brachiocephalic vessels (10 percent)
  • Descending aortic aneurysms
    • Distal to the left subclavian artery (40 percent)
  • Thoracoabdominal aneurysms (10 percent)

Aetiology

  • Arteriosclerosis
  • Medial degeneration of the aortic wall
  • Marfans syndrome
  • Trauma
  • Infection

Clinical

  • Usually have a history of HTN

Pathology

  • Medial degeneration of the aortic wall: Replacement of muscle cells & elastic lamina with mucoid-filled cystic spaces

Investigations

  • CXR: Convexity at R heart border
  • CT
  • MRA
  • Coronary angiogram – to screen for coexistent coronary artery disease

Management

  • Asymptomatic patients
  • Sporadic
    • If <5.5 Aggressive BP control and surveillance
    • If Aneurysm > 5.5 cm & asymptomatic = consider surgery
  • Marfan’s Syndrome
    • Intervention recommended at 4.5-5cm depending on risk factors
  • Other risk factors to consider small size of intervension
    • аոeսrуѕm expansion >0.5 cm per year, saccular аոеurуѕm, infectious аոеսrуѕm, female sex
  • Approach
    • Ascending Aorta
      • Open surgery using cardiopulmonary bypass and sometimes requires aortic root replacement with coronary artery reimplantation]
    • Descending Aorta
      • EVAR or Open

Prognosis

  • If untreated ≈ 50% of non-dissecting thoracic aneurysms will rupture
  • ↑ Risk of rupture:
    • Size
    • Underlying CT disorder
    • Dissection
    • COPD
    • Advancing age